Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide

Cytokine release syndrome (CRS) represents a life‐threatening side effect after haploidentical stem cell transplantation (Haplo‐SCT) with posttransplant cyclophosphamide (PT‐Cy). Factors predictive of CRS development is still a matter of debate. We retrospectively analyzed 102 consecutive patients r...

Descripción completa

Detalles Bibliográficos
Autores principales: Mariotti, Jacopo, Taurino, Daniela, Marino, Fabrizio, Bramanti, Stefania, Sarina, Barbara, Morabito, Lucio, De Philippis, Chiara, Di Vito, Clara, Mavilio, Domenico, Carlo‐Stella, Carmelo, Della Porta, Matteo, Santoro, Armando, Castagna, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943086/
https://www.ncbi.nlm.nih.gov/pubmed/31702882
http://dx.doi.org/10.1002/cam4.2607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943086/
https://www.ncbi.nlm.nih.gov/pubmed/31702882
http://dx.doi.org/10.1002/cam4.2607

Ejemplares similares